Molar expansion · Children and adults with a posterior crossbite, without a Class III skeletal relationship, cleft lip or palate (or both), or other…
Fixed tooth-borne Hyrax expander showed no clear difference in molar expansion compared with bonded expander plate (acrylic); GRADE not reported.
1 finding from 1 review
Oral health status and treatment needs · Arab children with special health care needs in Ras Al Khaimah
One study found very high caries (85.2%) and high unmet treatment needs among children with special healthcare needs, varying by disability type (narrative synthesis; not GRADE-rated).
1 finding from 1 review
Adverse effects · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
Topical triamcinolone acetonide may leads to lower adverse effects compared with topical tacrolimus (low certainty).
1 finding from 1 review
Pain (mean VAS score) · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
Topical clobetasol propionate showed no clear difference in pain (mean VAS score) compared with topical tacrolimus; GRADE not reported.
1 finding from 1 review
Clinical resolution · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
It is very uncertain whether topical clobetasol propionate changes clinical resolution compared with topical tacrolimus (very low certainty).
1 finding from 1 review
Clinical resolution · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
It is very uncertain whether topical triamcinolone acetonide changes clinical resolution compared with topical tacrolimus (very low certainty).
1 finding from 1 review
Adverse effects · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
It is very uncertain whether topical clobetasol propionate changes adverse effects compared with topical tacrolimus (very low certainty).
1 finding from 1 review
Pain resolution · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
The review found no eligible studies for this question.
1 finding from 1 review
Pain resolution · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
It is very uncertain whether topical clobetasol propionate changes pain resolution compared with topical tacrolimus (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Quality of life Drug resistance/microbial sensitivity Serious adverse events Lung function Hospitalisations Adverse events/side effects Number of participants colonised with P aeruginosa · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Primary patency ( · people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery
PTFE showed no clear difference in primary patency (24 months) compared with dacron (low certainty).
2 findings from 1 review
OR 1.23 [0.92, 1.65]
Studies not reported
Low
OR 1.67 [0.96, 2.9]
Studies not reported
Low
Secondary patency (24 months) · people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery
PTFE may leads to higher secondary patency (24 months) compared with dacron (low certainty).
1 finding from 1 review
OR 1.54 [1.04, 2.28]
Studies not reported
Low
Limb salvage · people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery
PTFE showed no clear difference in limb salvage (24 months) compared with dacron (low certainty).
1 finding from 1 review
OR 0.82 [0.27, 2.48]
Studies not reported
Low
Death or dependence · people with subarachnoid haemorrhage from a ruptured intracranial aneurysm
Endovascular coiling probably leads to lower poor outcome: death or dependence in daily activities (12 months) compared with neurosurgical clipping (moderate certainty).
2 findings from 1 review
Death from any cause (12 months) · people with subarachnoid haemorrhage from a ruptured intracranial aneurysm
Endovascular coiling showed no clear difference in death from any cause (12 months) compared with neurosurgical clipping (moderate certainty).
1 finding from 1 review
Delayed cerebral ischaemia · people with subarachnoid haemorrhage from a ruptured intracranial aneurysm
Endovascular coiling probably leads to lower delayed cerebral ischaemia (2–3 months) compared with neurosurgical clipping (moderate certainty).
1 finding from 1 review
Rebleeding · people with subarachnoid haemorrhage from a ruptured intracranial aneurysm
Endovascular coiling leads to higher rebleeding postprocedure up to 1 year compared with neurosurgical clipping (high certainty).
2 findings from 1 review
Complications from the intervention · people with subarachnoid haemorrhage from a ruptured intracranial aneurysm
Endovascular coiling showed no clear difference in complications from the intervention compared with neurosurgical clipping (low certainty).
1 finding from 1 review
Onset of PDPH · patients undergoing lumbar punctures with atraumatic needles (Whitacre, Atraucan, Sprotte, Cappe‐Deutsh, Pajunk, Gertie Marx, Durasafe,…
Larger atraumatic needles may leads to lower onset of PDPH compared with smaller atraumatic needles (low certainty).
1 finding from 1 review